Piper Jaffray Upgrades Bristol-Myers Squibb, Sees Valuation As Fair

By: via Benzinga
With the meaningful decline in the share price since Bristol-Myers Squibb Co(NYSE: BMY) announced its Q2 earnings, the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.